Non-steroidal anti-inflammatory drugs and CYP2C9 – Impacts of genetics and phenoconversion on the risk of adverse effects
- DOI
- 10.1016/j.clinbiochem.2026.111180
- Published
- 2026-12
- Container
- Clinical Biochemistry
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.clinbiochem.2026.111180,
title = {Non-steroidal anti-inflammatory drugs and CYP2C9 – Impacts of genetics and phenoconversion on the risk of adverse effects},
author = {M. Cameron and M.A. Katzman and C. Lalonde and N. Tetreault},
year = {2026},
journal = {Clinical Biochemistry},
doi = {10.1016/j.clinbiochem.2026.111180},
url = {https://doi.org/10.1016/j.clinbiochem.2026.111180}
}RIS
TY - JOUR TI - Non-steroidal anti-inflammatory drugs and CYP2C9 – Impacts of genetics and phenoconversion on the risk of adverse effects AU - M. Cameron AU - M.A. Katzman AU - C. Lalonde AU - N. Tetreault PY - 2026 JO - Clinical Biochemistry DO - 10.1016/j.clinbiochem.2026.111180 UR - https://doi.org/10.1016/j.clinbiochem.2026.111180 ER -
APA
Cameron, M., Katzman, M., Lalonde, C., & Tetreault, N. (2026). Non-steroidal anti-inflammatory drugs and CYP2C9 – Impacts of genetics and phenoconversion on the risk of adverse effects. Clinical Biochemistry. https://doi.org/10.1016/j.clinbiochem.2026.111180
Source records
- crossref · retrieved 2026-09-25T10:58:49.172Z